Secondary hematological malignancies after breast cancer chemotherapy

被引：14

作者：

Park, MJ ^{[1
]}

Park, YH ^{[1
]}

Ahn, HJ ^{[1
]}

Choi, W ^{[1
]}

Paik, KH ^{[1
]}

Kim, JM ^{[1
]}

Chang, YH ^{[1
]}

Ryoo, BY ^{[1
]}

Yang, SH ^{[1
]}

机构：

[1] Korea Inst Radiol & Med Sci, Div Haematol & Oncol, Dept Internal Med, Seoul 139706, South Korea

来源：

LEUKEMIA & LYMPHOMA | 2005年 / 46卷 / 08期

关键词：

breast cancer; secondary hematological malignancies; AML; MDS; lymphoma;

D O I：

10.1080/10428190500125705

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

According to several reports, the 10 year incidence of secondary acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) after systemic chemotherapy is approximately 1.5%. The cumulative risk increases by 0.25-1% for the first 8 years after treatment. We have reported only 6 cases of hematological malignancies (0.3%) after breast cancer chemotherapy in our institute. We detected 2 cases of secondary AML and 1 case of MDS, 19, 52 and 12 months, respectively, after systemic chemotherapy for breast cancer. Published data on the occurrence of secondary hematological malignancies other than AML or MDS in this setting are scarce. We encountered diffuse large B-cell lymphoma, angioimmunoblastic lymphoma and mantle cell lymphoma as secondary hematological malignancies after systemic chemotherapy for breast cancer.

引用

页码：1183 / 1188

页数：6

共 20 条

[1] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients [J].

Bernard-Marty, C ;

Mano, M ;

Paesmans, M ;

Accettura, C ;

Munoz-Bermeo, R ;

Richard, T ;

Kleiber, K ;

Cardoso, F ;

Lobelle, JP ;

Larismont, D ;

Piccart, MJ ;

Di Leo, A .

ANNALS OF ONCOLOGY, 2003, 14 (05) :693-698

[2] Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: A population-based study [J].

Chaplain, G ;

Milan, C ;

Sgro, C ;

Carli, PM ;

Bonithon-Kopp, C .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) :2836-2842

[3]

CURTIS RE, 1990, CANCER RES, V50, P2741

[4] RISK OF LEUKEMIA AFTER CHEMOTHERAPY AND RADIATION TREATMENT FOR BREAST-CANCER [J].

CURTIS, RE ;

BOICE, JD ;

STOVALL, M ;

BERNSTEIN, L ;

GREENBERG, RS ;

FLANNERY, JT ;

SCHWARTZ, AG ;

WEYER, P ;

MOLONEY, WC ;

HOOVER, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (26) :1745-1751

Diamandidou, E ;

Buzdar, AU ;

Smith, TL ;

Frye, D ;

Witjaksono, M ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2722-2730

[6] LEUKEMIA IN BREAST-CANCER PATIENTS FOLLOWING ADJUVANT CHEMOTHERAPY OR POSTOPERATIVE RADIATION - THE NSABP EXPERIENCE [J].

FISHER, B ;

ROCKETTE, H ;

FISHER, ER ;

WICKERHAM, DL ;

REDMOND, C ;

BROWN, A .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1640-1658

[7] RISK OF LEUKEMIA IN OVARIAN TUMOR AND BREAST-CANCER PATIENTS FOLLOWING TREATMENT BY CYCLOPHOSPHAMIDE [J].

HAAS, JF ;

KITTELMANN, B ;

MEHNERT, WH ;

STANECZEK, W ;

MOHNER, M ;

KALDOR, JM ;

DAY, NE .

BRITISH JOURNAL OF CANCER, 1987, 55 (02) :213-218

[8] Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients [J].

Kröger, N ;

Damon, L ;

Zander, AR ;

Wandt, H ;

Derigs, G ;

Ferrante, P ;

Demirer, T ;

Rost, G .

BONE MARROW TRANSPLANTATION, 2003, 32 (12) :1153-1157

[9] Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients:: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation [J].

Kröger, N ;

Zander, AR ;

Martinelli, G ;

Ferrante, P ;

Moraleda, JM ;

Da Prada, GA ;

Demirer, T ;

Socie, G ;

Rosti, G .

ANNALS OF ONCOLOGY, 2003, 14 (04) :554-558

[10] Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant [J].

Laughlin, MJ ;

McGaughey, DS ;

Crews, JR ;

Chao, NJ ;

Rizzieri, D ;

Ross, M ;

Gockerman, J ;

Cirrincione, C ;

Berry, D ;

Mills, L ;

Defusco, P ;

LeGrand, S ;

Peters, WP ;

Vredenburgh, JJ .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1008-1012

← 1 2 →